Valente Manuela 4

What Happened Manuela Valente, Chief People Officer of SOPHiA GENETICS SA (SOPH), sold 4,241 shares on July 6, 2026 in an open-market transaction. The reported weighted-average price was $5.05 per share for total proceeds of approximately $21,430. This was a sale (not a purchase) and appears routine rather than an indicator of a change in company outlook.

Key Details

• Transaction date: July 6, 2026 (Form 4 filed July 7, 2026).
• Shares sold: 4,241; weighted-average price reported: $5.05; total proceeds ≈ $21,430.
• Price range: shares were sold in multiple trades between $4.95 and $5.34 (footnote F2).
• Purpose/footnote: Sales were executed to satisfy tax withholding obligations related to RSU vestings on July 2 and July 3, 2026, and were effected under a pre-established Rule 10b5-1(c) trading plan (footnote F1). The filer indicates these were not discretionary trades.
• Shares owned after transaction: not specified in the provided filing.
• Timeliness: Filing was made the day after the transaction (no late filing flag indicated).

Context These shares were sold to cover tax withholding tied to restricted stock unit vesting — a common, administrative reason for insider sales. The transaction was executed under a 10b5-1 plan, which typically indicates pre-planned, non-discretionary sales. If you want the exact breakdown of how many shares sold at each price within the $4.95–$5.34 range, the filer has offered to provide that detail to the company, security holders, or the SEC staff upon written request.